Trial · NCT02935673
Adverse events147
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 147
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Eosinophilia | Blood and lymphatic system disorders | Placebo | 0 | 16 | |
| other | Eosinophilia | Blood and lymphatic system disorders | 750 mg LD / 250 mg MD Lumicitabine | 0 | 27 | |
| other | Eosinophilia | Blood and lymphatic system disorders | 1000 mg LD / 500 mg MD Lumicitabine | 1 | 6 | |
| other | Febrile Neutropenia | Blood and lymphatic system disorders | Placebo | 0 | 16 | |
| other | Febrile Neutropenia | Blood and lymphatic system disorders | 750 mg LD / 250 mg MD Lumicitabine | 0 | 27 | |
| other | Febrile Neutropenia | Blood and lymphatic system disorders | 1000 mg LD / 500 mg MD Lumicitabine | 1 | 6 | |
| other | Abdominal Pain Upper | Gastrointestinal disorders | Placebo | 0 | 16 | |
| other | Abdominal Pain Upper | Gastrointestinal disorders | 750 mg LD / 250 mg MD Lumicitabine | 2 | 27 | |
| other | Abdominal Pain Upper | Gastrointestinal disorders | 1000 mg LD / 500 mg MD Lumicitabine | 1 | 6 | |
| other | Diarrhoea | Gastrointestinal disorders | Placebo | 1 | 16 | |
| other | Diarrhoea | Gastrointestinal disorders | 750 mg LD / 250 mg MD Lumicitabine | 1 | 27 | |
| other | Diarrhoea | Gastrointestinal disorders | 1000 mg LD / 500 mg MD Lumicitabine | 0 | 6 | |
| other | Gastritis | Gastrointestinal disorders | Placebo | 0 | 16 | |
| other | Gastritis | Gastrointestinal disorders | 750 mg LD / 250 mg MD Lumicitabine | 0 | 27 | |
| other | Gastritis | Gastrointestinal disorders | 1000 mg LD / 500 mg MD Lumicitabine | 1 | 6 | |
| other | Asthenia | General disorders | Placebo | 1 | 16 | |
| other | Asthenia | General disorders | 750 mg LD / 250 mg MD Lumicitabine | 0 | 27 | |
| other | Asthenia | General disorders | 1000 mg LD / 500 mg MD Lumicitabine | 0 | 6 | |
| other | Chest Pain | General disorders | Placebo | 2 | 16 | |
| other | Chest Pain | General disorders | 750 mg LD / 250 mg MD Lumicitabine | 2 | 27 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02935673/events